Salmon calcitonin: a review of current and future therapeutic indications (Q37028810)

17 August 2017

1 reference

title

Salmon calcitonin: a review of current and future therapeutic indications (English)

1 reference

17 August 2017

therapeutic indication

1 reference

C H Chesnut

1

1 reference

17 August 2017

M Azria

2

1 reference

17 August 2017

S Silverman

3

1 reference

17 August 2017

M Engelhardt

4

1 reference

17 August 2017

M Olson

5

1 reference

17 August 2017

L Mindeholm

6

1 reference

17 August 2017

language of work or name

English

0 references

publication date

11 December 2007

1 reference

Osteoporosis International

17 August 2017

1 reference

17 August 2017

19

1 reference

17 August 2017

4

1 reference

17 August 2017

479-491

1 reference

https://scigraph.springernature.com/pub.10.1007/s00198-007-0490-1

17 August 2017

0 references

cites work

Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-007-0490-1

Goals of treatment for Paget's disease of bone

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00198-007-0490-1

Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis

21 January 2018

1 reference

12 December 2020

Rationale for the potential use of calcitonin in osteoarthritis.

1 reference

12 December 2020

Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study

1 reference

12 December 2020

Paget's disease of bone: experiences with 100 patients treated with salmon calcitonin

1 reference

12 December 2020

Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study

1 reference

12 December 2020

Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study.

1 reference

12 December 2020

25 years of salmon calcitonin: from synthesis to therapeutic use

1 reference

12 December 2020

Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group

1 reference

12 December 2020

Is bone mineral density predictive of fracture risk reduction?

1 reference

12 December 2020

Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial

1 reference

12 December 2020

Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture

1 reference

12 December 2020

Nasal calcitonin for treatment of established osteoporosis

1 reference

12 December 2020

Calcitonin promotes osteoclast survival in vitro

1 reference

12 December 2020

Salmon calcitonin in the acute management of hypercalcemia

1 reference

12 December 2020

Adjuvant analgesics in cancer pain management

1 reference

12 December 2020

Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis

1 reference

12 December 2020

Calcitonin is involved in cartilage homeostasis: is calcitonin a treatment for OA?

1 reference

12 December 2020

Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions

1 reference

12 December 2020

Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization

1 reference

12 December 2020

Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty

1 reference

12 December 2020

Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women

1 reference

12 December 2020

[Calcitonin in acute pain due to vertebral fracture in osteoporosis. Cooperative study]

1 reference

12 December 2020

The effect of rectal and nasal administration of salmon calcitonin in normal subjects

1 reference

12 December 2020

A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers

1 reference

12 December 2020

Acute effects of calcitonin nasal spray on serum C-telopeptide of type 1 collagen (CTx) levels in elderly osteopenic women with increased bone turnover.

1 reference

12 December 2020

Intranasal salmon calcitonin. A review of its pharmacological properties and potential utility in metabolic bone disorders associated with aging

1 reference

12 December 2020

Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy

1 reference

12 December 2020

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

1 reference

12 December 2020

Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis

1 reference

12 December 2020

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin

1 reference

12 December 2020

An evaluation of antibodies and clinical resistance to salmon calcitonin

1 reference

12 December 2020

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

12 December 2020

Histologic changes in Paget's disease treated with calcitonin

1 reference

12 December 2020

Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis

1 reference

12 December 2020

Analgesic efficacy of calcitonin for vertebral fracture pain

1 reference

12 December 2020

Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

Paget's disease. Radiological changes occurring in untreated patients and those on therapy with salmon calcitonin during two years' observation

1 reference

12 December 2020

Involvement of central serotonergic pathways in analgesia elicited by salmon calcitonin in the mouse.

1 reference

12 December 2020

Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study

1 reference

12 December 2020

Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint

1 reference

12 December 2020

Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment

1 reference

12 December 2020

Is Calcitonin an Important Physiological Substance?

1 reference

12 December 2020

Review of treatment modalities for postmenopausal osteoporosis

1 reference

12 December 2020

Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials

1 reference

12 December 2020

Association of low bone mass with vitamin d receptor gene and calcitonin receptor gene polymorphisms in juvenile idiopathic arthritis

1 reference

12 December 2020

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

1 reference

12 December 2020

Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome

1 reference

12 December 2020

Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics

1 reference

12 December 2020

Demonstration of a hypocalcemic factor (calcitonin) in commercial parathyroid extract

1 reference

12 December 2020

Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment

1 reference

12 December 2020

Calcitonin induced increase in ACTH, beta-endorphin and cortisol secretion.

1 reference

12 December 2020

Calcitonin for multiple fractures in Paget's disease

1 reference

12 December 2020

Effect of nasal salmon calcitonin on calcium and bone metabolism

1 reference

12 December 2020

Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography

1 reference

12 December 2020

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

1 reference

12 December 2020

Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfecta

1 reference

12 December 2020

Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial

1 reference

12 December 2020

Changes of bone remodelling surfaces and bone structure in Paget's disease following long-term treatment with calcitonin

1 reference

12 December 2020

The analgesic role of calcitonin following osteoporotic fracture

1 reference

12 December 2020

Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club

1 reference

12 December 2020

Forty years of calcitonin--where are we now? A tribute to the work of Iain Macintyre, FRS.

1 reference

12 December 2020

Managing acute osteoporotic vertebral fractures with calcitonin.

1 reference

12 December 2020

Quality-of-life issues in osteoporosis

1 reference

12 December 2020

Comparison of the renal and skeletal actions of calcitonin in the treatment of severe hypercalcaemia of malignancy

1 reference

12 December 2020

Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin

1 reference

12 December 2020

Central nervous system binding sites for calcitonin and calcitonin gene-related peptide

1 reference

12 December 2020

Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture

1 reference

12 December 2020

Role of serotonin in the analgesic activity of calcitonin

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Plasma type 1 collagen cross-linked C-telopeptide: a sensitive marker of acute effects of salmon calcitonin on bone resorption.

1 reference

12 December 2020

Femoral neck trabecular microstructure in ovariectomized ewes treated with calcitonin: MRI microscopic evaluation

1 reference

12 December 2020

Calcitonin: regional distribution of the hormone and its binding sites in the human brain and pituitary

1 reference

12 December 2020

Treatment of Paget's Disease of Bone with Synthetic Salmon Calcitonin

1 reference

12 December 2020

Calcitonin alters behaviour of isolated osteoclasts

1 reference

12 December 2020

Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers

1 reference

12 December 2020

Medical Management of Hypercalcemia

1 reference

12 December 2020

Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study

1 reference

12 December 2020

The Sensitivity of Isolated Osteoclasts to Morphological Transformation by Calcitonin*

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Effects of calcitonin on bone quality and osteoblastic function

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women

1 reference

12 December 2020

Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials

1 reference

12 December 2020

Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation

1 reference

12 December 2020

Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover

1 reference

12 December 2020

Biochemical assessment of acute and chronic treatment of Paget's bone disease with calcitonin and calcium with and without biphosphonate

1 reference

12 December 2020

Biphasic effect of calcitonin on tartrate-resistant acid phosphatase activity in isolated rat osteoclasts.

1 reference

12 December 2020

The effects of parathyroid hormone, colchicine, and calcitonin on the ultrastructure and the activity of osteoclasts in organ culture

1 reference

12 December 2020

Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.

1 reference

12 December 2020

Treatment of Paget's disease of bone with salmon calcitonin (author's transl)

1 reference

12 December 2020

The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study

1 reference

12 December 2020

The anti-bone-resorptive agent calcitonin also acts in vitro to directly increase bone formation and bone cell proliferation

1 reference

12 December 2020

Linkage map of the short arm of human chromosome 11: location of the genes for catalase, calcitonin, and insulin-like growth factor II.

1 reference

12 December 2020

Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats

1 reference

12 December 2020

Calcitonin receptor gene polymorphism in japanese women: correlation with body mass and bone mineral density

1 reference

12 December 2020

10.1007/S00198-007-0490-1

Identifiers

DOI

1 reference

17 August 2017

1 reference